Current recommendations for delaying noncardiac surgery following stent placement are outdated and lack evidence, according to an article published in the Journal of the American Medical Association.

New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and ...

There is still no definitive consensus about which anticoagulant is more effective during cardiac stent placement despite numerous existing studies, an editorial concluded in the New England Journal ...

A blocked coronary artery causing an acute heart attack must be opened immediately with a stent procedure. However, if other ...

This interactive animation describes about "coronary stent procedure" made by scientific animations. Stents are small expandable tubes used to treat weakened or narrowed arteries in the body. Coronary ...

Patients who require noncardiac surgery after receiving stents have lower rates of acute MI and/or coronary revascularization when the surgery is delayed at least 6 months, according to a study ...

One year of dual antiplatelet therapy with one of two potent P2Y12 inhibitors—ticagrelor or prasugrel—in people with Type 1 or Type 2 diabetes who had received a drug-eluting stent did not offer the ...

What is the current thinking with regard to coronary artery bypass grafting vs. stent placement in patients younger than 40 years? Each patient is assessed individually. Most prefer not to have ...

More than 375,000 American each year experience a heart attack, during which blood flow to a part of the heart is impeded by blocked arteries. Physicians often treat patients with stents, which prop ...

A stent thrombosis is a blood clot that forms within a coronary stent. It can be a complication of stent placement to open a narrowed artery. A coronary stent is a mesh tube that opens a narrowed or ...

A large, ambitious contrast of blood-thinning medications used during cardiac stent placement suggests that a very expensive drug offers no clear safety benefits over a much more affordable option, ...